SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: 13-Ethyl-17-hydroxy-18,19-dinor-17α-pregna-4,8(14)-dien-20-yn-3-one (as per EP)
Sinônimo: Norgestrel 8(14)-Dehydro Impurity
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=C1CC[C@@]2([H])C(CCC3=C(CC[C@@]4(O)C#C)[C@]4(CC)CC[C@@]32[H])=C1
Levonorgestrel EP Impurity A is chemically 13-Ethyl-17-hydroxy-18,19-dinor-17α-pregna-4,8(14)-dien-20-yn-3-one (as per EP). It is also known as Norgestrel 8(14)-Dehydro Impurity. Levonorgestrel EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Levonorgestrel EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levonorgestrel.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Comparative study on the application of capillary liquid chromatography and capillary electrochromatography for investigation of enantiomeric purity of the contraceptive drug levonorgestrel
Bezhan Chankvetadze a,b,, Irma Kartozia a , Chiyo Yamamoto c , Yoshio Okamoto c , Gottfried Blaschke
Journal of Pharmaceutical and Biomedical Analysis 30 (2003) 1897/1906
Analytical method development and method validation for determination assay and content uniformity of levonorgestrel by reversed-phase highperformance liquid chromatography
vikas kumar pal*, yogendra pal
Asian J Pharm Clin Res, Vol 13, Issue 4, 2020, 101-107